1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.2.1 RESEARCH OBJECTIVE
2.2.2 ASSUMPTIONS
2.2.3 LIMITATIONS
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
4 MARKET DYNAMICS
4.1 DRIVERS
4.2 RESTRAINTS
4.3 OPPORTUNITIES
4.4 MEGA TRENDS
4.5 MACROECONOMIC INDICATORS
5 MARKET FACTOR ANALYSIS
5.1 VALUE/SUPPLY CHAIN ANALYSIS
5.2 PORTER'S 5 FORCES ANALYSIS
6 CLINICAL NUTRITION MARKET: BY TYPES
6.1 INTRODUCTION
6.2 HISTORICAL MARKET GROWTH
6.3 Y-O-Y GROWTH PROJECTIONS BY TYPES
6.4 MARKET SIZE BY TYPES
6.4.1 INFANT NUTRITION
6.4.1.1 MILK BASED
6.4.1.2 SOY BASED
6.4.1.3 ORGANIC
6.4.1.4 PROBIOTIC/PREBIOTIC
6.4.1.5 OTHERS
6.4.2 ENTERAL NUTRITION
6.4.2.1 STANDARD
6.4.2.2 FOR CHRONIC ILLNESS
6.4.3 PARENTERAL NUTRITION
7 GLOBAL CLINICAL NUTRITION MARKET: BY REGION
7.1 INTRODUCTION
7.2 Y-O-Y GROWTH PROJECTIONS BY REGION
CLINICAL NUTRITION MARKET: BY TYPES
7.3 MARKET SIZE BY REGION
CLINICAL NUTRITION MARKET: BY TYPES
7.3.1 NORTH AMERICA
CLINICAL NUTRITION MARKET: BY TYPES
7.3.1.1 THE US
CLINICAL NUTRITION MARKET: BY TYPES
7.3.1.2 CANADA
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3 EUROPE
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.1 WESTERN EUROPE
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.1.1 GERMANY
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.1.2 FRANCE
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.1.3 ITALY
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.1.4 SPAIN
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.1.5 UK
CLINICAL NUTRITION MARKET: BY TYPES
7.3.3.2 EASTERN EUROPE
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4 ASIA-PACIFIC
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.1 ASIA
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.1.1 CHINA
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.1.2 INDIA
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.1.3 JAPAN
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.2 PACIFIC
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.2.1 AUSTRALIA
CLINICAL NUTRITION MARKET: BY TYPES
7.3.4.2.1 NEW ZEALAND
CLINICAL NUTRITION MARKET: BY TYPES
7.3.5 MIDDLE EAST & AFRICA
CLINICAL NUTRITION MARKET: BY TYPES
8 COMPANY LANDSCAPE
8.1 INTRODUCTION: KEY PLAYERS
8.2 MARKET SHARE ANALYSIS
8.3 KEY DEVELOPMENT STRATEGIES
9 COMPANY PROFILE
9.1 BAXTER INTERNATIONAL, INC
9.1.1 COMPANY OVERVIEW
9.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.1.3 FINANCIAL UPDATES
9.1.4 KEY DEVELOPMENTS
9.2 ABBOTT LABORATORIES
9.2.1 COMPANY OVERVIEW
9.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.2.3 FINANCIAL UPDATES
9.2.4 KEY DEVELOPMENTS
9.3 B. BRAUN MELSUNGEN AG
9.3.1 COMPANY OVERVIEW
9.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.3.3 FINANCIAL UPDATES
9.3.4 KEY DEVELOPMENTS
9.4 NESTLร S.A
9.4.1 COMPANY OVERVIEW
9.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.4.3 FINANCIAL UPDATES
9.4.4 KEY DEVELOPMENTS
9.5 GROUPEDANONE
9.5.1 COMPANY OVERVIEW
9.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.5.3 FINANCIAL UPDATES
9.5.4 KEY DEVELOPMENTS
9.6 MEAD JOHNSON NUTRITION COMPANY
9.6.1 COMPANY OVERVIEW
9.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.6.3 FINANCIAL UPDATES
9.6.4 KEY DEVELOPMENTS
9.7 FRESENIUS KABI AG
9.7.1 COMPANY OVERVIEW
9.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.7.3 FINANCIAL UPDATES
9.7.4 KEY DEVELOPMENTS
9.8 HOSPIRA, INC
9.8.1 COMPANY OVERVIEW
9.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.8.3 FINANCIAL UPDATES
9.8.4 KEY DEVELOPMENTS
9.9 PERRIGO COMPANY PLC
9.9.1 COMPANY OVERVIEW
9.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
9.9.3 FINANCIAL UPDATES
9.9.4 KEY DEVELOPMENTS
10 CONCLUSION
11 APPENDIX